ClotTriever® Thrombectomy System Use-Result Survey in Japan
Launched by INARI MEDICAL · Mar 6, 2025
Trial Information
Current as of May 10, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- • This is an all-comers survey of all patients treated with ClotTriever® Thrombectomy System in Japan.
About Inari Medical
Inari Medical is a pioneering medical device company focused on transforming the treatment of vascular diseases through innovative, minimally invasive solutions. With a commitment to advancing patient care, Inari specializes in developing technologies for the removal of thrombus and the restoration of blood flow, particularly in conditions such as deep vein thrombosis and pulmonary embolism. The company is dedicated to rigorous clinical research and development, ensuring that its products meet the highest standards of safety and efficacy. Inari Medical is at the forefront of enhancing procedural outcomes and improving quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ota, Gunma, Japan
Osaka, , Japan
Suita, Osaka, Japan
Kawasaki, Kanagawa, Japan
Ota, , Japan
Chuo Ward, Chiba, Japan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported